Rheumatoid Arthritis

You have full text access to this OnlineOpen article

Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case–control study†

  1. Zurab Nadareishvili1,
  2. Kaleb Michaud2,
  3. John M. Hallenbeck3,
  4. Frederick Wolfe4,‡,*

Article first published online: 30 JUL 2008

DOI: 10.1002/art.23935

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 59, Issue 8, pages 1090–1096, 15 August 2008

Additional Information

How to Cite

Nadareishvili, Z., Michaud, K., Hallenbeck, J. M. and Wolfe, F. (2008), Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case–control study. Arthritis & Rheumatism, 59: 1090–1096. doi: 10.1002/art.23935

Author Information

  1. 1

    Georgetown University Hospital, Washington, DC

  2. 2

    University of Nebraska Medical Center, Omaha, and National Data Bank for Rheumatic Diseases, Wichita, Kansas

  3. 3

    National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland

  4. 4

    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita

  1. ‡

    Dr. Wolfe has received consultant fees (less than $10,000) from Bristol-Myers Squibb.

*National Data Bank for Rheumatic Diseases, 1035 North Emporia, Suite 288, Wichita, KS 67214

  1. †

    The National Data Bank for Rheumatic Diseases has conducted safety registries for Centocor, Sanofi-Aventis, and Bristol-Myers Squibb, and has received research grants from Abbott, Amgen, Wyeth-Australia, Merck, and Pfizer.

Publication History

  1. Issue published online: 30 JUL 2008
  2. Article first published online: 30 JUL 2008
  3. Manuscript Accepted: 28 JAN 2008
  4. Manuscript Received: 9 SEP 2007

Funded by

  • Abbott
  • Amgen
  • Wyeth-Australia
  • Merck
  • Pfizer

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (130K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sofia Konisti, Serafim Kiriakidis, Ewa M. Paleolog, Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis, Nature Reviews Rheumatology, 2012, 8, 3, 153

    CrossRef

  2. 2
    Boulos Haraoui, Peter P. Liu, Kim A. Papp, Managing cardiovascular risk in patients with chronic inflammatory diseases, Clinical Rheumatology, 2012, 31, 4, 585

    CrossRef

  3. 3
    A. Kirstin Bacani, Sherine E. Gabriel, Cynthia S. Crowson, John A. Heit, Eric L. Matteson, Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?, Arthritis & Rheumatism, 2012, 64, 1
    Direct Link:
  4. 4
    B. Richioud, Y. Béjot, P. Ornetti, F. Ricolfi, J.-L. Sautreaux, D. Ben Salem, Polyarthrite rhumatoïde et nodules méningés, Revue Neurologique, 2012, 168, 4, 350

    CrossRef

  5. 5
    Ngayu Thairu, Serafim Kiriakidis, Peter Dawson, Ewa Paleolog, Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience, Angiogenesis, 2011, 14, 3, 223

    CrossRef

  6. 6
    Henry R. Kramer, Jon T. Giles, Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity, Arthritis Care & Research, 2011, 63, 4
    Direct Link:
  7. 7
    Adeline Ruyssen-Witrand, Bruno Fautrel, Alain Saraux, Xavier Le Loët, Thao Pham, Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review, Joint Bone Spine, 2011, 78, 1, 23

    CrossRef

  8. 8
    T. Nishioku, K. Furusho, A. Tomita, H. Ohishi, S. Dohgu, H. Shuto, A. Yamauchi, Y. Kataoka, Potential role for S100A4 in the disruption of the blood–brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis, Neuroscience, 2011, 189, 286

    CrossRef

  9. 9
    Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H. Solomon, Miguel A. Hernán, Paul M. Ridker, Dariush Mozaffarian, Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease, The American Journal of Cardiology, 2011, 108, 9, 1362

    CrossRef

  10. 10
    Yi-Ming Chen, Hsin-Hua Chen, Jong-Liang Lan, Der-Yuan Chen, Amélioration de la fonction cognitive, un bénéfice potentiel du traitement anti-TNF chez les patients âgés atteints de polyarthrite rhumatoïde, Revue du Rhumatisme, 2010, 77, 4, 406

    CrossRef

  11. 11
    Ewa M Paleolog, Angiogenesis in joint disease: the need for clinical data, International Journal of Clinical Rheumatology, 2010, 5, 4, 439

    CrossRef

  12. 12
    Tsuyoshi Nishioku, Atsushi Yamauchi, Fuyuko Takata, Takuya Watanabe, Koki Furusho, Hideki Shuto, Shinya Dohgu, Yasufumi Kataoka, Disruption of the blood–brain barrier in collagen-induced arthritic mice, Neuroscience Letters, 2010, 482, 3, 208

    CrossRef

  13. 13
    Elena Myasoedova, John M. Davis, Cynthia S. Crowson, Sherine E. Gabriel, Epidemiology of Rheumatoid Arthritis: Rheumatoid Arthritis and Mortality, Current Rheumatology Reports, 2010, 12, 5, 379

    CrossRef

  14. 14
    Yi-Ming Chen, Hsin-Hua Chen, Jong-Liang Lan, Der-Yuan Chen, Improvement of cognition, a potential benefit of anti-TNF therapy in elderly patients with rheumatoid arthritis, Joint Bone Spine, 2010, 77, 4, 366

    CrossRef

  15. 15
    Frederick Wolfe, Michael F. Marmor, Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus, Arthritis Care & Research, 2010, 62, 6
    Direct Link:
  16. 16
    Adeline Ruyssen-Witrand, Bruno Fautrel, Alain Saraux, Xavier Le Loët, Thao Pham, Risque cardiovasculaire associé à la corticothérapie à faible dose dans la polyarthrite rhumatoïde : revue de la littérature, Revue du Rhumatisme, 2010, 77, 6, 542

    CrossRef

  17. 17
    S. L. Westlake, A. N. Colebatch, J. Baird, N. Curzen, P. Kiely, M. Quinn, E. Choy, A. J. K. Ostor, C. J. Edwards, Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review, Rheumatology, 2010, 50, 3, 518

    CrossRef

  18. 18
    Arduino A. Mangoni, Richard J. Woodman, Andrew L. Gilbert, Kathleen M. Knights, Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community, Pharmacoepidemiology and Drug Safety, 2010, 19, 5
    Direct Link:
  19. 19
    Siba P. Raychaudhuri, Caroline T. Nguyen, Smriti K. Raychaudhuri, M. Eric Gershwin, Incidence and nature of infectious disease in patients treated with anti-TNF agents, Autoimmunity Reviews, 2009, 9, 2, 67

    CrossRef

  20. 20
    Frederick Wolfe, Kaleb Michaud, Out-of-pocket expenses and their burden in patients with rheumatoid arthritis, Arthritis Care & Research, 2009, 61, 11
    Direct Link:
  21. 21
    Frederick Wolfe, Kaleb Michaud, Predicting depression in rheumatoid arthritis: The signal importance of pain extent and fatigue, and comorbidity, Arthritis Care & Research, 2009, 61, 5
    Direct Link:
  22. You have free access to this content22
    S. Wang, K.-H. Yiu, M.-Y. Mok, G. C. Ooi, P.-L. Khong, K.-F. H. Mak, C.-P. Lau, K.-F. LAM, C.-S. Lau, H.-F. Tse, Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis, Journal of Internal Medicine, 2009, 266, 5
    Direct Link:
  23. You have free access to this content23
    Ewa M. Paleolog, The vasculature in rheumatoid arthritis: cause or consequence?, International Journal of Experimental Pathology, 2009, 90, 3
    Direct Link:
  24. 24
    Deborah P. M. Symmons, Ischemic stroke: Another feature of accelerated atherosclerosis in rheumatoid arthritis?, Arthritis Care & Research, 2008, 59, 8
    Direct Link:
  25. 25
    Jonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder, Christopher J Edwards, Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity, The Cochrane Library,
    Direct Link:
View Full Article (HTML) Get PDF (130K)